Contact Us | Press Room

Follow us on Twitter Find us on Facebook Share this Page Print this Page
Wednesday 11:24 CST, March 21, 2018

Donor Details

GlaxoSmithKline (GSK)

Donor Level:  Leader 

About GlaxoSmithKline

GlaxoSmithKline is one of the world’s leading research-based healthcare companies. Our scientists and other employees are united in a common effort to improve the quality of life by enabling people to do more, feel better and live longer. As an innovative pharmaceutical and vaccine company, we are focused on developing new treatments for a variety of conditions and providing access to innovative medicines and services. GSK’s Triple Solution for a Healthier America aims to improve health through better management of chronic diseases, a key driver of healthcare costs. The three-part approach encompasses preventing the onset of diseases, providing appropriate and sustained interventions, and investing in innovative research to discover new treatments and cures.

Statement of Support

GlaxoSmithKline is committed to collaboration with others in industry, academia, government and non-governmental organizations to improve patient outcomes and the quality of care in the United States. We are proud to support the Center for Transforming Healthcare’s efforts to solve healthcare’s critical safety and quality problems through sound research and the sharing of best practices. By working together across health care sectors, we can improve patient outcomes, ensure better coordination of care delivery, and lower healthcare costs.

Contact Name:Deborah Lee Fritz, PhD, MPH, Director Policy, Quality Standards